Select Page

A selection of health news from the University of Chicago and around the globe curated just for you.

Researchers find promise in new treatment for food allergies
UChicago is part of clinical trial that doctors hope will lead to an FDA-approved medication for people with peanut allergy. Christina Ciaccio featured. (UChicago News)

Save the germs
With modern medicine killing off whole categories of bacteria and viruses—including benign ones that promote health—Jack Gilbert and colleagues propose a way to preserve microbes that may rescue us one day. (The New York Times)

How might the appendix play a key role in Parkinson’s disease?
Those who have their appendixes removed in young adulthood run a nearly 20 percent lower risk of developing the neurodegenerative disorder decades later or not at all, study finds. (Scientific American)

Polsky Center’s Innovation Fund renamed to honor George P. Shultz
The decision to rename the Innovation Fund was the result of a $10 million gift to the Fund from University trustee and Booth alumna Mary A. Tolan, MBA ’92. (Polsky Center)

Jeffrey Hubbell named to National Academy of Medicine
Research by Hubbell—who co-founded UChicago food allergy startup ClostraBio—has led to tools and treatments, including nanoparticle vaccines and drug delivery systems, that combat diseases ranging from influenza and type 1 diabetes to tuberculosis and cancer. (UChicago News)